we analysed outcome in 206 consecutive male patients treated for metastatic non-seminomatous germ cell tumour ( nsgct ) of testicular or extragonadal origin treated with the pomb/ace ( cisplatin , vincristine , methotrexate , bleomycin , actinomycin d , cyclophosphamide , etoposide ) regimen after division into prognostic groups by commonly used clinical classification systems and definitions of adverse prognosis .
C0053926
pomb
C0005740
bleomycin